Gene · 2931
Papers2,889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,889
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Tumor Suppressor Protein TRAF3 Modulates GSK3 Activity and Susceptibility of B Lymphoma Cells to GSK3 Inhibition. | Cancers (Basel) | 2022 | 36291813 | PubTator, text mining | PubMed |
| Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells. | Cells | 2022 | 36291101 | PubTator, text mining | PubMed |
| Potential of Epidermal Growth Factor-like Peptide from the Sea Cucumber Stichopus horrens to Increase the Growth of Human Cells: In Silico Molecular Docking Approach. | Mar Drugs | 2022 | 36286420 | PubTator, text mining | PubMed |
| Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication. | Sci Signal | 2022 | 36282911 | PubTator, text mining | PubMed |
| Imaging and Editing the Phospholipidome. | Acc Chem Res | 2022 | 36278840 | PubTator, text mining | PubMed |
| TIMELESS is a key gene mediating thrombogenesis in COVID-19 and antiphospholipid syndrome. | Sci Rep | 2022 | 36241659 | PubTator, text mining | PubMed |
| Characterization of the Molecular Alterations Induced by the Prolonged Exposure of Normal Colon Mucosa and Colon Cancer Cells to Low-Dose Bisphenol A. | Int J Mol Sci | 2022 | 36232920 | PubTator, text mining | PubMed |
| Current understanding of epigenetics role in melanoma treatment and resistance. | Cancer Cell Int | 2022 | 36224606 | PubTator, text mining | PubMed |
| Network pharmacology-based screening of the active ingredients and mechanisms of evodiae fructus anti-glioblastoma multiforme. | Medicine (Baltimore) | 2022 | 36181021 | PubTator, text mining | PubMed |
| Akt: a key transducer in cancer. | J Biomed Sci | 2022 | 36180910 | PubTator, text mining | PubMed |
| Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial PfGSK3/PfPK6 with Activity against Blood Stage Parasites In Vitro. | J Med Chem | 2022 | 36166733 | PubTator, text mining | PubMed |
| Post-translational dysregulation of glucose uptake during exhaustive cycling exercise in vastus lateralis muscle of healthy homozygous carriers of the ACE deletion allele. | Front Physiol | 2022 | 36148310 | PubTator, text mining | PubMed |
| Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors. | Viruses | 2022 | 36146786 | PubTator, text mining | PubMed |
| The Impact of Oxidative Stress and AKT Pathway on Cancer Cell Functions and Its Application to Natural Products. | Antioxidants (Basel) | 2022 | 36139919 | PubTator, text mining | PubMed |
| GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target. | Cells | 2022 | 36139472 | PubTator, text mining | PubMed |
| Extend the Survival of Human Sperm In Vitro in Non-Freezing Conditions: Damage Mechanisms, Preservation Technologies, and Clinical Applications. | Cells | 2022 | 36139420 | PubTator, text mining | PubMed |
| Aerobic Exercise Regulates Apoptosis through the PI3K/Akt/GSK-3β Signaling Pathway to Improve Cognitive Impairment in Alzheimer's Disease Mice. | Neural Plast | 2022 | 36124291 | PubTator, text mining | PubMed |
| TGF-β signaling in the tumor metabolic microenvironment and targeted therapies. | J Hematol Oncol | 2022 | 36115986 | PubTator, text mining | PubMed |
| Deciphering SARS CoV-2-associated pathways from RNA sequencing data of COVID-19-infected A549 cells and potential therapeutics using in silico methods. | Medicine (Baltimore) | 2022 | 36107502 | PubTator, text mining | PubMed |
| Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36077764 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2931/papers?page=18